ODYSSEY HEALTH, INC. sold 58.7% of their position (10K shares) of ORAGENICS INC on the open market
Open‑market sale worth $43.6K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/16/2025ACC: 0001683168-25-004526
-10K
Net shares
Net seller
$43.6K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
10K disposed
Non-Derivative Transactions2
Common Stock - OGEN
Direct
Shares
−5K
Price / share
$4.27
Trade value
$21.35K
% of position
29.3%
6/13/2025
17.04K→12.04K
Common Stock - OGEN
Direct
Shares
−5K
Price / share
$4.45
Trade value
$22.25K
% of position
41.5%
6/16/2025
12.04K→7.04K
Total
Net shares
−10K
Net value
-$43.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock - OGEN Direct | 6/13/2025 | S · Sale | −5K | $4.27 | $21.35K | 29.3% | 17.04K | 12.04K |
| Common Stock - OGEN Direct | 6/16/2025 | S · Sale | −5K | $4.45 | $22.25K | 41.5% | 12.04K | 7.04K |
| Total | −10K | -$43.60K | ||||||
Derivative Transactions0
No derivative transactions reported